83 related articles for article (PubMed ID: 16601955)
21. The regulatory domains of CNA have different effects on the inhibition of CN activity by FK506 and CsA.
Wang HL; Du YW; Xiang BQ; Lin WL; Wei Q
IUBMB Life; 2007 Jun; 59(6):388-93. PubMed ID: 17613169
[TBL] [Abstract][Full Text] [Related]
22. Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.
Kissinger CR; Parge HE; Knighton DR; Lewis CT; Pelletier LA; Tempczyk A; Kalish VJ; Tucker KD; Showalter RE; Moomaw EW
Nature; 1995 Dec; 378(6557):641-4. PubMed ID: 8524402
[TBL] [Abstract][Full Text] [Related]
23. Expression, purification, and molecular characterization of Plasmodium falciparum FK506-binding protein 35 (PfFKBP35).
Yoon HR; Kang CB; Chia J; Tang K; Yoon HS
Protein Expr Purif; 2007 May; 53(1):179-85. PubMed ID: 17289400
[TBL] [Abstract][Full Text] [Related]
24. Properties of flaky affinity resin with co-continuous structure.
Mori T; Tanaka A; Kubo T; Kaya K; Sakamoto M; Hosoya K
Bioorg Med Chem; 2008 Feb; 16(4):1983-91. PubMed ID: 18037297
[TBL] [Abstract][Full Text] [Related]
25. [FK506-binding proteins and neurodegenerative diseases].
Zhao LQ; Xiao JH; Huang W; Li S
Yao Xue Xue Bao; 2002 Sep; 37(9):743-8. PubMed ID: 12567904
[No Abstract] [Full Text] [Related]
26. Preparation and properties of calcium-dependent resins with increased selectivity for calmodulin.
Hart RC; Hice RE; Charbonneau H; Putnam-Evans C; Cormier MJ
Anal Biochem; 1983 Nov; 135(1):208-20. PubMed ID: 6670741
[TBL] [Abstract][Full Text] [Related]
27. Everolimus and sirolimus antagonize tacrolimus based calcineurin inhibition via competition for FK-binding protein 12.
van Rossum HH; Romijn FP; Smit NP; de Fijter JW; van Pelt J
Biochem Pharmacol; 2009 Apr; 77(7):1206-12. PubMed ID: 19154728
[TBL] [Abstract][Full Text] [Related]
28. Crystal structure of the FK506 binding domain of Plasmodium falciparum FKBP35 in complex with FK506.
Kotaka M; Ye H; Alag R; Hu G; Bozdech Z; Preiser PR; Yoon HS; Lescar J
Biochemistry; 2008 Jun; 47(22):5951-61. PubMed ID: 18465874
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals.
Ishihara T; Nakajima N; Kadoya T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2141-4. PubMed ID: 20591751
[TBL] [Abstract][Full Text] [Related]
30. The complex of FK506-binding protein 12 and FK506 inhibits calcineurin phosphatase activity and IgE activation-induced cytokine transcripts, but not exocytosis, in mouse mast cells.
Fruman DA; Bierer BE; Benes JE; Burakoff SJ; Austen KF; Katz HR
J Immunol; 1995 Feb; 154(4):1846-51. PubMed ID: 7530743
[TBL] [Abstract][Full Text] [Related]
31. Bifunctional molecules evade cytochrome P(450) metabolism by forming protective complexes with FK506-binding protein.
Marinec PS; Lancia JK; Gestwicki JE
Mol Biosyst; 2008 Jun; 4(6):571-8. PubMed ID: 18493655
[TBL] [Abstract][Full Text] [Related]
32. Interaction of tacrolimus(FK506) and its metabolites with FKBP and calcineurin.
Tamura K; Fujimura T; Iwasaki K; Sakuma S; Fujitsu T; Nakamura K; Shimomura K; Kuno T; Tanaka C; Kobayashi M
Biochem Biophys Res Commun; 1994 Jul; 202(1):437-43. PubMed ID: 7518678
[TBL] [Abstract][Full Text] [Related]
33. Rapid isolation of novel FK506 binding proteins from multiple organisms using gDNA and cDNA T7 phage display.
Piggott AM; Kriegel AM; Willows RD; Karuso P
Bioorg Med Chem; 2009 Oct; 17(19):6841-50. PubMed ID: 19740670
[TBL] [Abstract][Full Text] [Related]
34. High-throughput fluorescence polarization method for identification of FKBP12 ligands.
Bollini S; Herbst JJ; Gaughan GT; Verdoorn TA; Ditta J; Dubowchik GM; Vinitsky A
J Biomol Screen; 2002 Dec; 7(6):526-30. PubMed ID: 14599350
[TBL] [Abstract][Full Text] [Related]
35. [Effects of FK506 on neuroendocrine system--special reference to the effects on growth hormone secretory systems].
Sato M
Jpn J Antibiot; 2001 Dec; 54 Suppl C():37-40. PubMed ID: 12575414
[No Abstract] [Full Text] [Related]
36. Evaluation of synthetic FK506 analogues as ligands for the FK506-binding proteins 51 and 52.
Gopalakrishnan R; Kozany C; Gaali S; Kress C; Hoogeland B; Bracher A; Hausch F
J Med Chem; 2012 May; 55(9):4114-22. PubMed ID: 22455444
[TBL] [Abstract][Full Text] [Related]
37. Improving affinity chromatography resin efficiency using semi-continuous chromatography.
Mahajan E; George A; Wolk B
J Chromatogr A; 2012 Mar; 1227():154-62. PubMed ID: 22265178
[TBL] [Abstract][Full Text] [Related]
38. Reduction of nonspecific binding proteins to self-assembled monolayer on gold surface.
Furuya M; Haramura M; Tanaka A
Bioorg Med Chem; 2006 Jan; 14(2):537-43. PubMed ID: 16314102
[TBL] [Abstract][Full Text] [Related]
39. A reassessment of the inhibitory capacity of human FKBP38 on calcineurin.
Weiwad M; Edlich F; Erdmann F; Jarczowski F; Kilka S; Dorn M; Pechstein A; Fischer G
FEBS Lett; 2005 Mar; 579(7):1591-6. PubMed ID: 15757646
[TBL] [Abstract][Full Text] [Related]
40. The precise chemical-physical nature of the pharmacore in FK506 binding protein inhibition: ElteX, a New class of nanomolar FKBP12 ligands.
Martina MR; Tenori E; Bizzarri M; Menichetti S; Caminati G; Procacci P
J Med Chem; 2013 Feb; 56(3):1041-51. PubMed ID: 23301792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
